Meeting
2023 ASCO Annual Meeting
Prevalence of pathogenic germline variants in a cohort of patients with early onset non-small cell lung cancer (EOLUNG).
Authors
Maria Jove
Catalan Institute of Oncology, Hospital Duran i Reynals, IDIBELL. Medical Oncology, Hospitalet, Spain
Maria Jove , Mireia Gausachs , Joaquim Bosch-Barrera , Enric Carcereny , Alex Teulé , Miguel Mosteiro , Marta Pineda , Eva Tornero , Sara Hijazo-Pechero , Jose Carlos Ruffinelli , Jesús Brenes , Alejandro I. Hernandez , Claudia Fina , Elia Sais , Joan Brunet , Marta Doménech , Maria Saigi , Teresa Moran , Conxi Lazaro , Ernest Nadal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10630)
DOI
10.1200/JCO.2023.41.16_suppl.10630
Abstract #
10630
Poster Bd #
263
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Real-world treatment patterns and clinical outcomes post standard of care (SOC) among patients (pts) with metastatic non-small cell lung cancer (mNSCLC) with and without actionable genomic alterations (AGAs) in the United States (US).
First Author: Ruchit Shah
Poster
2023 ASCO Annual Meeting
A nation-wide genomic screening project for further development of targeted therapies in treatment-refractory non–small-cell lung cancer (LC-SCRUM-TRY).
First Author: Hiroki Izumi
Poster
2021 ASCO Annual Meeting
Impact of rapid multigene assays with short turnaround time (TAT) on the development of precision medicine for non-small cell lung cancer (NSCLC).
First Author: Shingo Matsumoto
Poster
2020 ASCO Virtual Scientific Program
Establishment of the first international large-scale, genomic screening platform to identify patients with rare oncogene drivers in non-small cell lung cancer (NSCLC) in East Asia.
First Author: Shingo Matsumoto